Others

Sms Pharmaceuticals Ltd. - Outcome of Board Meeting

| Updated on May 27, 2019 Published on May 27, 2019

With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held on today, inter-alia considered and approved the following:

1. Standalone Financial Results for the Quarter (Audited) and year ended (Audited) as on 31st March, 2019.
2. Consolidated Audited Financial Results for the year ended as on 31st March, 2019.
3. Auditors Report for Standalone and Consolidated Financial Statements.
4. Recommended a dividend of Re. 0.25 (25 %) per equity share of Re.1/- (Rupee One) each (face value), for the financial year ended 31st March, 2019. The dividend will be paid subject to the approval of the shareholders at the ensuing Annual General Meeting.
Accordingly, please find enclosed the following:

1. Declaration under Reg. 33(3)(d).

2. Standalone Financial Results for the Quarter ended (Audited) and year ended (Audited) as on 31st March, 2019.


3. Consolidated Audited Financial Results for the year ended as on 31st March, 2019.

4. Auditors Report for Standalone and Consolidated Financial Statements for the year ended 31st March, 2019.

The meeting commenced at 12.00 Noon and concluded at 02.00 PM.

Please take the above intimation on your records.

Pdf Link: Sms Pharmaceuticals Ltd. - Outcome of Board Meeting

Source : BSE - www.bseindia.com

Published on May 27, 2019
This article is closed for comments.
Please Email the Editor